6-143471538-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003630.3(PEX3):​c.524-19T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.392 in 1,598,930 control chromosomes in the GnomAD database, including 125,878 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 10569 hom., cov: 32)
Exomes 𝑓: 0.40 ( 115309 hom. )

Consequence

PEX3
NM_003630.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.831

Publications

9 publications found
Variant links:
Genes affected
PEX3 (HGNC:8858): (peroxisomal biogenesis factor 3) The product of this gene is involved in peroxisome biosynthesis and integrity. It assembles membrane vesicles before the matrix proteins are translocated. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause Zellweger syndrome (ZWS). [provided by RefSeq, Oct 2008]
PEX3 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 10A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • peroxisome biogenesis disorder 10B
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 6-143471538-T-C is Benign according to our data. Variant chr6-143471538-T-C is described in ClinVar as Benign. ClinVar VariationId is 259107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.446 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX3NM_003630.3 linkc.524-19T>C intron_variant Intron 6 of 11 ENST00000367591.5 NP_003621.1 P56589

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX3ENST00000367591.5 linkc.524-19T>C intron_variant Intron 6 of 11 1 NM_003630.3 ENSP00000356563.4 P56589
PEX3ENST00000367592.5 linkc.392-19T>C intron_variant Intron 5 of 6 5 ENSP00000356564.1 Q7Z6V3

Frequencies

GnomAD3 genomes
AF:
0.366
AC:
55650
AN:
151862
Hom.:
10562
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.269
Gnomad AMI
AF:
0.555
Gnomad AMR
AF:
0.455
Gnomad ASJ
AF:
0.347
Gnomad EAS
AF:
0.337
Gnomad SAS
AF:
0.252
Gnomad FIN
AF:
0.338
Gnomad MID
AF:
0.364
Gnomad NFE
AF:
0.419
Gnomad OTH
AF:
0.393
GnomAD2 exomes
AF:
0.379
AC:
94969
AN:
250842
AF XY:
0.373
show subpopulations
Gnomad AFR exome
AF:
0.264
Gnomad AMR exome
AF:
0.458
Gnomad ASJ exome
AF:
0.358
Gnomad EAS exome
AF:
0.331
Gnomad FIN exome
AF:
0.343
Gnomad NFE exome
AF:
0.418
Gnomad OTH exome
AF:
0.397
GnomAD4 exome
AF:
0.395
AC:
571886
AN:
1446952
Hom.:
115309
Cov.:
30
AF XY:
0.392
AC XY:
282395
AN XY:
720704
show subpopulations
African (AFR)
AF:
0.259
AC:
8603
AN:
33196
American (AMR)
AF:
0.458
AC:
20456
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.359
AC:
9322
AN:
26000
East Asian (EAS)
AF:
0.350
AC:
13828
AN:
39520
South Asian (SAS)
AF:
0.254
AC:
21822
AN:
85748
European-Finnish (FIN)
AF:
0.352
AC:
18768
AN:
53320
Middle Eastern (MID)
AF:
0.411
AC:
2323
AN:
5646
European-Non Finnish (NFE)
AF:
0.413
AC:
454111
AN:
1099018
Other (OTH)
AF:
0.379
AC:
22653
AN:
59836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
15574
31147
46721
62294
77868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13706
27412
41118
54824
68530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.366
AC:
55672
AN:
151978
Hom.:
10569
Cov.:
32
AF XY:
0.364
AC XY:
27019
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.268
AC:
11120
AN:
41466
American (AMR)
AF:
0.455
AC:
6953
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.347
AC:
1204
AN:
3470
East Asian (EAS)
AF:
0.338
AC:
1748
AN:
5172
South Asian (SAS)
AF:
0.253
AC:
1218
AN:
4818
European-Finnish (FIN)
AF:
0.338
AC:
3564
AN:
10560
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.419
AC:
28432
AN:
67912
Other (OTH)
AF:
0.390
AC:
819
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1799
3598
5396
7195
8994
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
542
1084
1626
2168
2710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.394
Hom.:
3950
Bravo
AF:
0.375
Asia WGS
AF:
0.286
AC:
993
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 21, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Peroxisome biogenesis disorder 10B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Peroxisome biogenesis disorder 10A (Zellweger) Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
12
DANN
Benign
0.68
PhyloP100
0.83
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs22908; hg19: chr6-143792675; COSMIC: COSV62568174; API